AI-powered search
AI-powered search

2024 Virtual Grand Rounds

2024 Virtual Grand Rounds Session 6: May 1, 2024 - Treating Acne with Devices and Contact Dermatitis - What Allergens Should I Care about in 2024?


Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:

Wednesday, May 1, 2024

8 PM ET / 5 PM PT

Treating Acne with Devices and Contact Dermatitis 

What Allergens Should I Care About in 2024?


In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

May 2, 2024

Expiration Date:

May 2, 2025

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Identify the most common allergen groups that provoke allergic contact dermatitis

  • Recognize the potential for systemic exposure to contact allergens can cause a patterned dermatitis

  • Describe the mechanism of action of lasers and light sources in treating acne.

  • Incorporate lasers and light sources into acne treatment protocols

Intended Audience

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

April Armstrong, MD, MPH

Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA

David Cohen, MD, MPH

Charles C. and Dorothea E. Harris Professor
Vice Chairman for Clinical Affairs
New York University School of Medicine
New York, NY

Joshua Zeichner, MD

Director of Cosmetic and Clinical Research 
Icahn School of Medicine at Mount Sinai 
New York, NY

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

April W. Armstrong, MD, MPH

Grant/Research Support: BMS, Leo, UCB, Lilly, Dermavant, Dermira, Pfizer, AbbVie, ASLAN, BI, EPI, Incyte, Janssen 

Consultant: Lilly, Novartis, Ortho, SUN, Dermavant, Dermira, Sanofi Regeneron, Pfizer, Parexel 

Joshua Zeichner, MD

Consultant: Abbvie, Allergan, Arcutis, Beiersdorf, Dermavant, Galderma, Incyte, Kenvue, L'Oreal, Pfizer, Procter & Gamble, Sun, Unilever, UCB

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved